Events
-
-
-
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
GLP‑1 receptor agonist use and survival in older adults with cancer and type 2 diabetes
A large retrospective cohort study has found that glucagon-like peptide-1 receptor agonists (GLP-1RAs) are associated…
Good prognosis for men with prostate cancer treated according to guidelines
Most men who are treated for prostate cancer according to modern guidelines have good survival…
ENDO 2025: Study finds strong link between acromegaly and increased cancer risk
People with the rare growth hormone disorder acromegaly have a significantly higher risk of developing…
Digital-first healthcare solutions to enhance patient experiences and outcomes
Greater uptake of digital-driven solutions in healthcare management could significantly improve patient experiences while saving providers time and money in…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.